Effect of Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation on Skin Carotenoid Concentration: A Six-Month, Placebo-Controlled Crossover Study
NCT06965426 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2025-09-24
Summary
To compare skin carotenoid scores over 12 weeks of individuals randomized to placebo or MacuHealth and comparing that to a 12 week crossover evaluation.
Conditions
- Macular Degenerative Disease
Interventions
- OTHER
-
Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation
Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation
Sponsors & Collaborators
-
MacuHealth
collaborator INDUSTRY -
Insight Eyecare Specialties, Inc. dba Vision Source Eyecare,
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-06-01
- Primary Completion
- 2026-01-15
- Completion
- 2026-12-01
Countries
- United States
Study Locations
More Related Trials
-
The Influence of Lutein Supplements on Age-related Macular Degeneration
NCT01042860 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a New Eye-specific Multivitamin Formula in Participants at Risk of Age-related Macular Degeneration (AMD)
NCT03946085 ·Status: COMPLETED ·Phase: NA
-
Effects of Antioxidants on Human Macular Pigments
NCT00718653 ·Status: COMPLETED ·Phase: NA
-
The Effects of Lutein and Zeaxanthin Supplementation on Vision in Patients With Albinism
NCT02200263 ·Status: COMPLETED ·Phase: NA
-
Lutein/Zeaxanthin and Omega-3 Supplementation in Persons Over Age 60
NCT00121589 ·Status: COMPLETED ·Phase: PHASE1
-
Long Term Effects of Lutein/Zeaxanthin and Omega-3- Supplementation on Optical Density of AMD Patients (LUTEGA)
NCT00763659 ·Status: COMPLETED ·Phase: NA
-
Effects of Lutein in Retinitis Pigmentosa
NCT00029289 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Macular Pigment and Visual Performance in Glaucoma Patients
NCT03959592 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Addition of 20mg/Day Zeaxanthin to Triple Therapy Treatment Options for Age Related Macular Degeneration (ARMD)
NCT01527435 ·Status: COMPLETED
-
Effects of Lutein Supplementation on Macular Pigment Optical Density and Visual Acuity in Patients With Age-related Macular Degeneration
NCT00879671 ·Status: COMPLETED ·Phase: NA
-
Lutein, Zeaxathin, and Fish Oil Supplementation
NCT06489873 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Polypodium Leucotomos Extract Decreasing UVA Premutagenic and Photoaging Markers
NCT00520910 ·Status: COMPLETED ·Phase: PHASE2
-
Carotenoid Supplementation and Retinal Health in Healthy Adults
NCT07314411 ·Status: RECRUITING ·Phase: NA
-
Effects of Xanthophylls on Optical Density
NCT01316198 ·Status: COMPLETED ·Phase: NA
-
Eye and Carotenoid Augmentation Research and Evaluation (EyeCARE)
NCT06848101 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Effects of a Carotenoid Intervention on Cognitive Function
NCT02023645 ·Status: UNKNOWN ·Phase: NA
-
Relationships Between Macular Pigment Optical Density and Lacquer Cracks in High Myopic Patients.
NCT02205632 ·Status: COMPLETED ·Phase: NA
-
Macular Pigment Measurements in Eye & Other Tissues
NCT03022773 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Long Term Effects of Lutein/Zeaxanthin and Omega-3- Supplementation for Two More Years (LUTEGA 2)
NCT01648660 ·Status: COMPLETED ·Phase: NA
-
Lutein & Zeaxanthin in Pregnancy - Carotenoid Supplementation During Pregnancy: Ocular and Systemic Effects
NCT03750968 ·Status: COMPLETED ·Phase: PHASE2
-
Antioxidant Systems and Age-Related Macular Degeneration
NCT00668213 ·Status: COMPLETED
-
MPOD in Macular Teleangiectasia Following Supplementation of Lutein and Zeaxanthin
NCT00568828 ·Status: UNKNOWN
-
Effects of Sea Buckthorn Oil and Lutein on Eye Health
NCT02379169 ·Status: UNKNOWN ·Phase: NA
-
Investigation of the Genetic and Environmental Determinants of MP Including Response to Supplementation
NCT01778231 ·Status: COMPLETED ·Phase: NA
-
"Night Vision and Carotenoids"
NCT04741763 ·Status: COMPLETED ·Phase: NA